Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports

Background: Glatiramer acetate (GA) and Interferon (IFN) beta-1a are used as first-line disease-modifying treatments for multiple sclerosis (MS). In this systematic review, we summarized case reports and case series of adverse side effects of GA and IFN beta-1a in MS patients. Methods: Without any r...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastkar, Mohsen, Ghajarzadeh, Mahsa, Sahraian, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460926/
https://www.ncbi.nlm.nih.gov/pubmed/38011449
http://dx.doi.org/10.18502/cjn.v22i2.13340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460926/
https://www.ncbi.nlm.nih.gov/pubmed/38011449
http://dx.doi.org/10.18502/cjn.v22i2.13340

Ejemplares similares